Traffic Roots Audience Pixel

Post categorized under: PDx News & Insights

PDx News & Insights

PathogenDx delivers viral testing solutions for a new era dominated by the global pandemic, and is at the forefront of cannabis, and food testing. We are answering the challenge of individuals, communities and the moment itself, while monitoring the global conversation around pathogen testing to offer even more powerful solutions. Catch up on the latest news driving the future of safe.


  • Lit & Lucid Episode 149 – Creating Efficiency With Cannabis Pathogen Testing with Milan Patel, Co-Founder & CEO of PathogenDx

    PathogenDx Co-founder and CEO Milan Patel stopped by the Lit & Lucid Podcast to discuss the ease of testing Cannabis crops and the importance of testing in regards to consumer safety. The group spoke in lengths about the present and future of Cannabis pathogen testing technology and how PathogenDx separates itself from others on the market.

    Listen here »

  • BOFC Live E.396: Fast Cannabis Testing Capabilities Helping the Sector Right Now

    Co-Founder and CEO Milan Patel connects to talk about PathogenDx, the unique processes we utilize for cannabis lab and in-grow environmental testing as well as the path forward to testing in the United States.

    Read full article »

  • Arizona Companies PathogenDx, Formula Diagnostics and Bashas’ Food City Offer Safe, Accurate and Fast COVID-19 Testing to Uninsured Arizonans

    PathogenDx, Formula Diagnostics (“FDX”), a provider of clinical laboratories and health services, and Bashas’ Food City, a family-owned-and-operated grocer, announced a community service partnership, which is bringing uninsured individuals in Phoenix and Mesa access to COVID-19 testing at no cost. The Arizona-based companies will be dedicating time and volunteering resources to deliver safe, accurate and fast tests, with results available within 24 to 48 hours.

    More here »

  • PathogenDx CEO Milan Patel Calls on President Joe Biden to Implement Newest State of the Art Diagnostic Technologies in Global Battle against COVID-19 Variants

    While the FDA is considering Emergency Use Authorization submissions for SARS-CoV-2 variant genotyping assays, PathogenDx co-founder and CEO Milan Patel issued the following letter to U.S. President Joe Biden, urging him to implement state of the art diagnostic technologies in the battle against the COVID-19 pandemic.

    Read letter »

  • CEO Milan Patel Speaks on Recent Trends in Cannabis and Hemp Testing

    “We’ve seen the USDA weigh in on hemp, and that is the first signal of what the future could look like. Given the unique position cannabis sits in with respect to a plant that has medicinal values, can be sold as edibles (food), and as supplementals, the regulatory framework cuts across major agencies and will take some time to unfold.”

    More here »

  • PathogenDx, Axiology Labs Ink Deal to Distribute Detectx-Cv Assay Across Africa and Thailand

    Axiology Labs will distribute PathogenDx’s Detectx-Cv Clade Variant equipment and testing kits to its lab network across Africa and Thailand. Axiology Labs will install, train, support, and service its locations across these markets in identifying SARS-CoV-2 variants.

    Read more »

  • AOAC Approves PathogenDx QuantX Assay

    On August 11, the company received an AOAC Performance Tested Methods Certificate for the QuantX yeast and mold test. QuantX was designed specifically with cannabis and hemp testing in mind, and to expedite and simplify microbiological testing. QuantX quantifies the total amount of yeast and mold in a sample while also measuring against safety standards.

    More here »

  • Our leadership in COVID-19 testing aimed at detecting variants

    The flexibility of the PathogenDx Microarray has led to ultra-rapid, low-cost testing to identify specific variants extending the pandemic. Is this information vital? Well, with COVID-19 not going anywhere, we continue to innovate how to deliver greater insight that can help inform point-of-care insights and public health decisions.

    More here »

  • Cannabinoid Connect Podcast 236: Milan Patel, PathogenDx

    Co-Founder and CEO Milan Patel guests on the Cannabinoid Connect Podcast to talk with host Kevin Carrillo about topics ranging from providing disruptive DNA-based pathogen testing technology and solutions to building the future of safe in the cannabis, botanical, food and agricultural industries.

    Listen and watch here »